Panel: Clinical Trial Diversity & Digital Accessibility: The Future of Digital Accessibility in Pharma
Session details:
With January 2025 and the significant change in approaches to equity, inclusion, and belonging, what is the future for Digital Accessibility in Pharma? Explore WHY disability inclusion and accessibility is still important, WHAT Information & Communication Technologies are in scope, and HOW can Inclusive Design be applied across the Pharma digital ecosystem. Relatable, relevant, responsive, responsible!
Because, we all know, diversity is a key success factor in clinical trials: advancing science and medicine through a variety of lived experiences and living conditions – particularly, people with disabilities. Digital accessibility design standards for patients with disabilities can be critical to clinical trial access, engagement, adherence, and measurement. With the Web Content Accessibility Guidelines (WCAG) design standards for Information & Communication Technologies (ICT), explore the WHY, the HOW, and the WHAT for digital accessibility in clinical trial diversity.
- WHY: disability inclusion in health equity
- WHAT: clinical trial digital ecosystem
- HOW: inclusive design standards
